EUVIMEDEUVIMED entdecken
Übersichtsarbeit

All the might of the osteocyte: emerging roles in chronic kidney disease

Lauren V Albrecht, Renata C Pereira, Isidro B Salusky

Kidney International · 2023

DOI: 10.1016/j.kint.2023.08.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Kidney International, 2023. Verfasst von Lauren V Albrecht und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental and Cell Biology, School of Biological Sciences, University of California, Irvine, Irvine, California, USA; Department of…. Hauptthemen laut MEDLINE: Osteocytes, Renal Insufficiency, Chronic, Chronic Kidney Disease-Mineral and Bone Disorder. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, David Geffen School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteocytes are the most abundant type of bone cell and play crucial roles in bone health. Osteocytes sense mechanical stress and orchestrate osteoblasts and osteoclasts to maintain bone density and strength. Beyond this, osteocytes have also emerged as key regulators of organ crosstalk, and they function as endocrine organs via their roles in secreting factors that mediate signaling within their neighboring bone cells and in distant tissues. As such, osteocyte dysfunction has been associated with the bone abnormalities seen across a spectrum of chronic kidney disease. Specifically, dysregulated osteocyte morphology and signaling have been observed in the earliest stages of chronic kidney disease and have been suggested to contribute to kidney disease progression. More important, US Food and Drug Administration-approved inhibitors of osteocytic secreted proteins, such as fibroblast growth factor 23 and sclerostin, have been used to treat bone diseases. The present mini review highlights new research that links dysfunctional osteocytes to the pathogenesis of chronic kidney disease mineral and bone disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteocytesRenal Insufficiency, ChronicChronic Kidney Disease-Mineral and Bone DisorderHumansAnimalsSignal TransductionFibroblast Growth Factor-23Fibroblast Growth FactorsBone RemodelingAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

CKD-MBDkidney-induced osteoporosisosteocytic proteins

Substanzen

Fibroblast Growth Factor-23Fibroblast Growth FactorsSOST protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Developmental and Cell Biology, School of Biological Sciences, University of California, Irvine, Irvine, California, USA; Department of Pharmaceutical Sciences, School of Pharmacy, University of California…
  • Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. Electronic address: isalusky@mednet.ucla.edu.

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • David Geffen School of Medicine
  • University of California Irvine
  • School of Pharmacy, University of Southern California
  • Chao Family Comprehensive Cancer Center

Zitieren

APA

Albrecht, L. V., Pereira, R. C., & Salusky, I. B. (2023). All the might of the osteocyte: emerging roles in chronic kidney disease. Kidney International. https://doi.org/10.1016/j.kint.2023.08.009

Vancouver

Albrecht LV, Pereira RC, Salusky IB. All the might of the osteocyte: emerging roles in chronic kidney disease. Kidney International. 2023. doi:10.1016/j.kint.2023.08.009

BibTeX
@article{Albrecht2023,
  author = {Albrecht, Lauren V and Pereira, Renata C and Salusky, Isidro B},
  title = {All the might of the osteocyte: emerging roles in chronic kidney disease},
  journal = {Kidney International},
  year = {2023},
  doi = {10.1016/j.kint.2023.08.009}
}
Kostenlos starten →